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STUDY QUESTION: What is the knowledge, anxiety levels and attitudes of infertile couples towards coronavirus disease 2019
(COVID-19) and its impact on undergoing self-funded treatment cycles?
SUMMARY ANSWER: In spite of a high level of awareness about COVID-19, anxiety levels were low and many participants wanted to
continue fertility treatment during the pandemic.
WHAT IS KNOWN ALREADY: The COVID-19 pandemic has strained the already overburdened public health infrastructure in many
of the resource-limited settings across the world. After an initial decision to suspend fertility treatments, regulatory authorities advocated
phased resumptions of treatment. Owing to limited healthcare resources and the detrimental impact of COVID-19 on the economy and
job losses, fertility services have been disproportionately affected. It is important to understand the perceptions of infertile couples, who
are the key stakeholders in shared decision-making, especially for self-funded treatments, on the continuation of fertility treatment during
the current COVID-19 pandemic.
STUDY DESIGN, SIZE, DURATION: This was a questionnaire-based cross-sectional study conducted among 502 participants (251 in-
fertile couples) at a tertiary level infertility clinic between May 2020 and November 2020. The study recruitment period (6 months) coin-
cided with the increase and peak of COVID-19 infection in India. The study included infertile couples who had attended the clinic either
for assessment or fertility treatment.
PARTICIPANTS/MATERIALS, SETTING, METHODS: An interviewer administered the questionnaire survey, which was conducted
in two stages for each participant. In the first stage, knowledge about COVID-19 and anxiety levels caused by the ongoing pandemic were
assessed using a validated Generalized Anxiety Disorder-7 (GAD-7) tool. Following this, all the participants were provided with a COVID-
19 information pamphlet. Subsequently, in the second stage, participants were administered another questionnaire to assess their attitudes
towards fertility treatment and pregnancy during the COVID-19 pandemic.
MAIN RESULTS AND THE ROLE OF CHANCE: The results showed that the knowledge levels and awareness about COVID-19 was
high among infertile couples attending the infertility clinic. The majority of the participants were aware of the mode of spread (87.6–93.4%
correct answers to different questions), common symptoms (64.1–96.2%) and the importance of preventative measures (95.6–97.4%).
Most of the participants (474/502; 94.4%) did not show anxiety when being assessed using GAD-7. A vast majority (96.5–99.2%) of the
participants were in agreement with the need for following preventative measures for reducing the spread of COVID-19. About one-third
of the participants wanted to delay the fertility treatment until the pandemic is over (166/502; 33.1%). Approximately 42.2% (212/502) of
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the participants did not feel the need to suspend fertility treatment during the pandemic. Further analysis revealed that participants’ educa-
tion levels significantly influenced the desire to continue fertility treatment: participants with lower levels of education (below graduate)
were less likely to continue fertility treatment (adjusted odds ratio 0.34, 95% CI, 0.12–0.98).
LIMITATIONS, REASONS FOR CAUTION: Questionnaire-based responses could have limited the ability of the interviewer to cap-
ture the entire range of thoughts and views of the participants on the COVID pandemic and their fertility treatments. Furthermore, a lan-
guage barrier was encountered for some couples for which assistance from a translator was sought.
WIDER IMPLICATIONS OF THE FINDINGS: Given the impact of infertility and the associated stigma, public health policy makers,
regulatory authorities and fertility societies should consider a way to sustain the treatment options and develop appropriate guidelines to
continue treatment, particularly when much of the world is experiencing the second and third waves of the COVID pandemic.
STUDY FUNDING/COMPETING INTEREST(S): This study has not received any specific grant from funding agencies in the public,
commercial or not-for-profit sectors. M.S.K. is an associate editor with Human Reproduction Open. The other authors have no competing
interests to declare.
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Introduction
The world is experiencing an unprecedented public health crisis owing
to the rapidly evolving coronavirus disease 2019 (COVID-19) pan-
demic. More than 103 million people have been diagnosed with
COVID-19 and over 2.2 million deaths have been recorded within the
year since the pandemic began (Johns Hopkins Coronavirus Resource
Center, 2021). While the pandemic is stabilizing in some parts of the
world, other regions across the world are experiencing the second
and third waves of infection. However, the successful development
and approval of several vaccines against severe acute respiratory syn-
drome coronavirus 2 (SARS-CoV-2), the virus causing COVID-19, has
improved the prospects of returning to normalcy. It is predicted that
the COVID-19 pandemic will have a long-lasting impact on the society.
Drastic changes are likely to be seen in the way we travel and conduct
day to day commercial or non-commercial activities, with social dis-
tancing becoming the new norm.
In the initial response to the evolving COVID-19 pandemic, health-
care regulatory authorities recommended and implemented a morato-
rium on all the non-urgent medical interventions, including fertility
treatment, to divert and deploy the available healthcare resources in
the fight against the pandemic. With the infection rates plateauing in
many countries, health authorities have allowed a gradual resumption
of other health services after carefully considering local factors.
In the second week of March 2020, the European Society of Human
Reproduction and Embryology (ESHRE) advised infertility patients to
avoid pregnancy during the pandemic (ESHRE News, 2021). An
updated recommendation also advised withholding ART treatment.
Subsequently, the ESHRE COVID-19 working group and the American
Society for Reproductive Medicine (ASRM) published guidelines for
restarting ART treatment in a phased manner in areas with decreasing
rates of infection (ASRM, 2020; ESHRE News, 2021). Other fertility
societies and regulatory authorities also developed guidelines for man-
aging fertility treatment and pregnancy care during the COVID-19 pan-
demic (COVID-19 (coronavirus disease)—Fertility and Pregnancy j
Cochrane Gynaecology and Fertility, 2021; Icmr.gov.in, 2021). In later
updates, the importance of reinitiating fertility treatment was
highlighted owing to the negative impact of the time lag on treatment
outcomes and possible psychological effects on anxious infertile cou-
ples (ASRM, 2020; ESHRE News, 2021).
Infertile couples who are waiting for the resumption of fertility treat-
ment may become stressed and worried about the uncertainty sur-
rounding their treatment and the impact of COVID-19 on pregnancy
(Lambalk et al., 2020). Recently, the International Federation of
Fertility Societies/ESHRE issued a statement on COVID vaccination
for women who are considering pregnancy to facilitate decision-making
for couples planning to undergo fertility treatment (COVID19 vaccina-
tion, 2021).
WHAT DOES THIS MEAN FOR PATIENTS?
The effects of the coronavirus disease 2019 (COVID-19) pandemic have been profound, especially in the low- and middle-income coun-
tries, requiring a major reorganization of healthcare services. The pandemic has posed immense financial and travel-related challenges for
couples who have difficulty in having a baby and are seeking access to fertility services for consultation and treatment. We carried out a
survey to understand the levels of knowledge, anxiety and attitudes towards the COVID-19 pandemic in infertile couples undergoing self-
funded treatment. A total of 502 participants who attended our centre for evaluation or fertility treatment were individually surveyed. The
results showed that the awareness level about COVID-19 was high and anxiety levels were low among those who participated in our
study. Approximately 42.2% of the participants were willing to start or continue with fertility treatment during the pandemic, in spite of
the risks associated with COVID-19. Education level had an influence on the decision to continue fertility treatment: those with a lower
level were less willing to continue. So, it is important that the regulatory authorities identify ways to continue providing fertility services, es-
pecially for when new waves of infection occur.

































































































In resource-limited areas across the world, the psychosocial impact
of infertility is deep and access to fertility treatment is limited and often
self-financed (van Balen and Bos, 2009; Patel et al., 2018).
Furthermore, the COVID-19 pandemic has strained the already over-
burdened public health infrastructure in many of these developing
countries. Owing to limited healthcare resources and other factors,
such as a declining economy and job losses, fertility services have been
disproportionately affected. Hence, it is important to understand the
views of infertile couples, who are the key stakeholders in a shared de-
cision-making process, especially for self-funded cycles, on the continu-
ation of fertility treatment during the current COVID-19 pandemic.
As the second most populous country in the world, there is wide-
spread concern about the impact of the COVID-19 pandemic in India,
with the second wave of COVID infections on the rise (Estate et al.,
2021). With the gradual resumption of healthcare services across the
country, we planned this study to assess the knowledge of infertile
couples about COVID-19 and their attitudes towards the infection/
fertility treatment, which may influence their decision-making regarding
the uptake of fertility treatment. In addition, we wanted to estimate
the anxiety levels among the couples who were undergoing evaluation
and treatment for infertility.
Materials and methods
A cross-sectional study was conducted between May 2020 and
December 2020 at Christian Medical College (CMC), Vellore, India, in
a tertiary level infertility unit. The study recruitment period (June–
November 2020, 6 months) coincided with the increase and peak of
COVID-19 infection in India. Ethical approval for the study was
obtained from the Institutional Review Board (IRB) of CMC, Vellore,
India (expedited clearance dated 12 May 2020; IRB 12852).
All infertile couples who visited the Department of Reproductive
Medicine at CMC Vellore, during the study period, either for outpa-
tient evaluation or to undergo fertility treatment, including IVF, were
eligible to participate in the study. Participants with suspected COVID-
19 or those with diagnosed COVID-19 were excluded from the study.
The details of the study were explained to the eligible couples, and all
those who were willing to participate were recruited to the study after
obtaining a written informed consent.
An interviewer administered questionnaire survey was conducted in
two stages. Both stages of the interview were completed on the same
day. During the first stage, knowledge about COVID-19 and their anxi-
ety levels related to the ongoing pandemic were assessed. A validated
tool (Generalized Anxiety Disorder-7, GAD-7) was used to measure
anxiety levels. After completion of the first questionnaire, the partici-
pants were given a pamphlet containing general information about the
COVID-19, as well as information on fertility treatment and
pregnancy-related concerns during the COVID-19 medical crisis.
Participants were given adequate time to go through the pamphlet and
understand the contents. They were also provided with the opportu-
nity to clarify any treatment or pregnancy-related queries with the
treating clinicians. Each of the participants was advised to report back
to the interviewer for the second stage of the interview after they had
gone through the information pamphlet, understood the content and
were comfortable to do so. The time taken by individual participants
to attend the second stage of the interview varied, with an average
interval of 2–3 h. In the second stage, participants were administered
another questionnaire by the same interviewer to assess their attitude
regarding fertility treatment and pregnancy during the COVID-19 pan-
demic. Each individual participant was interviewed separately by clini-
cians working in the department. The questionnaire was administered,
while the participants were waiting for their consultation. While ad-
ministering the questionnaire, COVID-related social distancing rules,
masks and other necessary precautions were followed as per the pro-
tocol laid down by the local government authorities. Owing to the
COVID pandemic restrictions, we recruited eligible couples during
their routine visits to the clinic for either investigations or treatment to
avoid any additional visits for the purpose of the study. Only one or
two randomly chosen eligible couples were interviewed per day to
avoid overcrowding. The clinicians who conducted the survey were
not involved in the treatment of the participating couples, to reduce
both participant and assessor bias. Other clinical and demographic in-
formation were obtained from medical records and/or directly from
the participants.
Statistical methods
For continuous data, the descriptive statistics mean, SD and, for non-
normally distributed interval and ordinal data, median (interquartile
range [IQR]) was presented. For categorical data, the number of par-
ticipants and proportions were presented. A statistical approach called
the dyadic logistic multilevel modelling was used to analyse the couple
data to assess partner, individual and couple characteristics that were
related to the individual opinion. The dyadic regression model was
performed to assess the demographic and treatment-related factors
which influenced the partcipants’ response on continuation of fertility
treatment during the COVID-19 pandemic. For the regression model-
ling, relevant parameters, such as age, family income, education, dura-
tion of infertility, previous parity, reason for a visit and the type of
planned treatment, for the couples were considered. All tests were
two-sided at a¼ 0.05 level of significance. All analysis was carried out
using Statistical Package for Social Sciences (SPSS) software Version
21.0 (IBM Corp, Armonk, NY, USA).
Results
During the recruitment period, a total of 1313 couples visited the de-
partment for either evaluation or fertility treatment. Among those
who were eligible, a total of 251 infertile couples who were willing to
participate were included in the study and 502 participants were indi-
vidually interviewed (researcher administered questionnaire). The de-
mographic characteristics of the study population are summarized in
Table I. The mean age of female and male partners were 29.3 (§4.5)
and 34.1 (§4.8) years, respectively. The majority of the participants
had an undergraduate degree (45.4% females and 42.2% males).
About 75% of the female participants were unemployed, while 25.1%
of the male participants were semi-skilled workers.
The median duration of infertility was 3 years (IQR: 2, 6), as de-
scribed in Table II. A total of 53 couples (21.1%) visited the outpa-
tient department for infertility evaluation, while the remaining 198
couples (78.9%) were planning to undergo fertility treatment. Among
those who were planning to undergo fertility treatment, 37.9% were



































..scheduled for IVF, while the remainder would undergo alternate fertil-
ity treatments such as ovulation induction, ovarian stimulation with IUI
or fertility enhancing surgery (such as laparoscopic cystectomy and lap-
aroscopic ovarian drilling) (Table II).
Knowledge levels of the participants about COVID-19 symptoms
(64.1–96.2%) and the mode of spread (87.6–93.4%) were high
(Table III). Most of the participants were aware of the highly infectious
nature of the disease (94%), the susceptibility of elderly (93.4%) and
the importance of preventative measures (95.6–97.4%). For questions
related to pregnancy and continuation of fertility treatment during the
COVID-19 pandemic, the responses were mixed. While 46.4% of par-
ticipants believed that pregnancy needs to be avoided during the pan-
demic, 52.4% of the participants thought that fertility treatment should
be continued.
Anxiety levels were assessed among participants using the GAD-7
scale and the vast majority of the participants (94.4%) did not show
anxiety (GAD score < 5) (Supplementary Table SI). While 23
participants showed mild anxiety (4.6%), 3 (0.6%) participants showed
moderate levels and 2 showed severe levels of anxiety (0.3%). Anxiety
levels were compared between the male and female participants and
there was no significant difference between sexes (Supplementary
Table SII). Among the 28 participants who had varying levels of anxi-
ety, 19 reported that their daily activities were affected to some extent
by anxiety (Supplementary Table SIII). Four participants found it very
difficult to perform their daily activities because of their severe anxiety
levels.
In the second stage of the study, attitudes towards the COVID-19
pandemic and fertility-related issues were assessed using the Likert
scale (Table IV). A vast majority (96.5–99.2%) of the participants
were in agreement with the need for following preventative measures
for reducing the spread of COVID-19 infection with social distanc-
ing, wearing face masks and self-isolating in the event of contracting
the infection. About 52.2% agreed or strongly agreed that preg-
nancy should be avoided during the COVID-19 pandemic, while
............................................................................................................................................................................................................................
Table I Baseline demographic characteristics of the study population.
Parameters Number of couples (n 5 251) Percentage (%)
Place Tamil Nadu 203 80.9
Other Indian states 43 17.1
Foreign nationals 5 2.0
Family income, INR (per month) <20 000 150 59.8
20 000–50 000 73 29.1
>50 000 28 11.2
Number of participants Percentage (%)
Female partner’s education Primary 11/251 4.4
Secondary 34/251 13.5
Higher secondary 41/251 16.3
Graduate 114/251 45.4
Post graduate 51/251 20.3
Male partner’s education Primary 14/251 5.6
Secondary 38/251 15.1
Higher secondary 36/251 14.3
Graduate 106/251 42.2
Post graduate 57/251 22.7


























Table II Clinical characteristics of the study population.
Parameters Number of couples (n 5 251) Percentage (%)
Type of infertility Primary 199 79.3
Secondary 52 20.7
Duration of infertility (years)a 3 2, 6
Couples with previous child 21 8.4
H/o fertility treatment 119 47.4
Reason for present visit Evaluation 53 21.1
Treatment 198 78.9
Type of treatment (n¼ 198) OI 58 29.3
COSþ IUI 35 17.7
IVF 75 37.9
Fertility enhancing surgery 10 5.1
Fertile period 20 10.1
Number of participants (n 5 502) Percentage (%)........................................................................................................................................................................................................................................................................
Previous medical illnessb Diabetes 24 4.8
Hypertension 6 1.2
Thyroid disease 34 6.8
Heart disease 0 0
Bronchial asthma 4 0.8
COS, controlled ovarian stimulation; OI, ovulation induction.
a Presented as median, interquartile range.
b Calculated per individual (n¼ 502).
............................................................................................................................................................................................................................
Table III Assessment of participants’ knowledge regarding the COVID-19 pandemic.
Questions Yes (%) No (%) Don’t know (%)
Modes of spread Close contact with infected person 469 (93.4) 33 (6.6) 0 (0)
Touching surfaces contaminated by
respiratory secretions of infected people
440 (87.6) 37 (7.4) 25 (5.0)
Complaints Fever with or without chills 482 (96.0) 20 (4.0)
Cough 483 (96.2) 19 (3.8)
Breathing difficulty 479 (95.4) 23 (4.6)
Loss of smell 322 (64.1) 180 (35.9)
Everyone positive for COVID-19 will develop severe symptoms 174 (34.7) 299 (59.6) 29 (5.8)
Patients without obvious symptoms can spread the disease 410 (81.7) 67 (13.3) 25 (5.0)
COVID-19 is a highly infectious disease 472 (94.0) 22 (4.4) 8 (1.6)
Elderly are at higher risk for developing severe disease 469 (93.4) 18 (3.6) 15 (3.0)
Preventative measures can largely reduce the spread of COVID-19 489 (97.4) 10 (2.0) 3 (0.6)
Isolating patients with COVID-19 can prevent its spread 480 (95.6) 14 (2.8) 8 (1.6)
Pregnancy should be avoided during the COVID-19 pandemic 233 (46.4) 188 (37.5) 81 (16.1)
Fertility treatments should be avoided during the COVID-19 pandemic 162 (32.3) 263 (52.4) 77 (15.3)
COVID-19, coronavirus disease 2019.











Table IV Assessment of attitude towards the COVID-19 pandemic and fertility treatment (during the COVID-19 pandemic)
using the Likert scale.
Strongly
agree (%)




Spread of COVID-19 can be decreased by
preventative measures
385 (76.7) 113 (22.5) 2 (0.4) 2 (0.4) 0 (0)
Should follow social distancing (wearing mask, gloves) 419 (83.5) 80 (15.9) 2 (0.4) 1 (0.2) 0 (0)
Will you isolate yourself in case you develop COVID 19? 429 (85.5) 55 (11.0) 11 (2.2) 4 (0.8) 3 (0.6)
Pregnancy should be avoided during the
COVID-19 pandemic
154 (30.7) 108 (21.5) 90 (17.9) 136 (27.1) 14 (2.8)
Fertility treatments should be avoided during the
COVID-19 pandemic
118 (23.5) 96 (19.1) 76 (15.1) 166 (33.1) 46 (9.2)
Delaying fertility treatments may compromise
chances of getting pregnant
80 (15.9) 182 (36.3) 71 (14.1) 148 (29.5) 21 (4.2)
Deferment of fertility treatments owing to inconvenience
caused by travel restrictions and additional screening
34 (6.8) 104 (20.7) 64 (12.7) 258 (51.4) 42 (8.4)
Routine screening for COVID-19 prior to
fertility treatments
245 (48.8) 143 (28.5) 34 (6.8) 68 (13.5) 12 (2.4)
Termination of fertility treatment in case of
developing COVID-19
209 (41.6) 181 (36.1) 29 (5.8) 71 (14.1) 12 (2.4)
Delay of fertility treatment until pandemic is settled 42 (8.4) 124 (24.7) 50 (10.0) 220 (43.8) 66 (13.1)
COVID-19, coronavirus disease 2019.
............................................................................................................................................................................................................................
Table V Dyadic logistic multilevel model to analyse couple data with possible covariates for individuals agreeing to continue










n 5 290 n 5 212
(%) (%)
Age (years)a 31.7 (5.5) 31.8 (5.4) 1.02 (0.95, 1.08) 0.65 1.01 (0.94, 1.08) 0.77
Family income,
INR (per month)
>50 000 28 (9.7) 28 (13.2) 0.31 (0.07, 1.39) 0.13 0.24 (0.06, 1.15) 0.07
50 000 (Ref) 262 (90.3) 184 (86.8)
Education Below graduate 90 (31.0) 82 (38.7) 0.49 (0.18, 1.32) 0.16 0.34 (0.12, 0.98) 0.04*
Graduate and
above (Ref)
200 (69.0) 130 (61.3)
Duration of infertility
(years)b
3 (2.0, 6.1) 3 (2.0, 6.0) 1.05 (0.92, 1.21) 0.43 1.11 (0.95, 1.30) 0.20
Previous child No 269 (92.8) 191 (90.1) 0.98 (0.18, 5.38) 0.97 0.98 (0.18, 5.45) 0.96
Yes (Ref) 21 (7.2) 21 (9.9)
Reason for visit Treatment 231 (79.7) 165 (77.8) 1.70 (0.54, 5.37) 0.37 1.44 (0.42, 4.90) 0.56
Evaluation (Ref) 59 (20.3) 47 (22.2)
Treatment type ART 85 (36.8) 65 (39.4) 0.93 (0.33, 2.57) 0.88 0.67 (0.20, 2.25) 0.52
Non ART (Ref) 146 (63.2) 100 (60.6)
aOR, adjusted odds ratio: adjusted for age, family income, education, duration of infertility, previous parity, reason for visit and the type of treatment planned; INR, Indian Rupee; IQR,
interquartile range; Ref, reference.
aPresented as mean, SD.
bPresented as median, IQR.
*Statistically significant.

































































































17.9% provided an equivocal (neither agree nor disagree) response.
When asked about the continuation of fertility treatment during
the COVID-19 pandemic, 42.3% of participants did not feel the
need to suspend fertility treatment during the pandemic, while
15.1% of the participants were equivocal in their response. More
than three-quarters of the participants (77.3–77.7%) were in favour
of routine screening for the COVID-19 infection during fertility
treatment and termination of treatment in the event of contracting
the infection. Approximately one-third of the participants wanted
to delay the fertility treatment until the pandemic is over (33.1%).
Differences in the male and female partners’ responses on attitudes
towards the COVID-19 pandemic were evaluated and no signifi-
cant difference was found for any assessment questions on atti-
tudes (Supplementary Table SIV).
Influences of demographic or treatment-related factors on the par-
ticipants’ response to continuation of fertility treatment during the
COVID-19 pandemic were explored (Table V). Only the education
level of the participants significantly influenced the desire to continue
fertility treatment. Participants with lower levels of educational qualifi-
cations (below graduate level) were less likely to continue fertility
treatment during the pandemic compared to those with higher levels
(graduate and above) (adjusted odds ratio 0.34, 95% CI, 0.12–0.98;
P¼ 0.04). Other factors, such as age, family income, duration of infer-
tility, previous child and treatment type, did not significantly impact the
fertility treatment decision.
Discussion
The current study findings suggest that knowledge levels and aware-
ness about COVID-19 were very high among infertile couples attend-
ing the infertility clinic. This could possibly be a result of the massive
and sustained information campaign run by the government and other
agencies. The vast majority of the participants were in agreement
about the need for adhering to preventative measures to curb the
spread of infection by SARS-CoV-2. In spite of the perceived COVID-
19 risks around fertility treatment, the questionnaire survey revealed
that 42% of the participants did not feel the need to suspend fertility
treatment during the COVID pandemic while 15% remained ambiva-
lent. Only the education level of the participants significantly influenced
the decision to continue fertility treatment during the pandemic. Only
a small number of participants displayed some level of anxiety, with a
significant majority only having had mild levels of anxiety.
A cross-sectional online survey from the UK evaluated the impact
of closure of fertility clinics in April 2020 on patients (n¼ 450) under-
going fertility treatment (Boivin et al., 2020). The investigators
reported that patients considered suspension of fertility treatment as
having a negative impact on their lives and would lead to an increase
in pre-existing difficulties caused by fertility issues. The majority of the
participants in the study expressed that they were worried, anxious
and frustrated because of the uncertainties arising out of the COVID
pandemic. Another online survey conducted in Canada in April 2020
evaluated the views and emotional reactions of women (n¼ 181)
whose fertility treatment was postponed or discontinued owing to the
COVID pandemic (Marom Haham et al., 2021). The investigators of
this study reported that 43% of the participants disagreed with the
guidelines and the majority (82%) wanted to continue their treatment
if given the choice, with 60% of the participants reporting anxiety. The
decision to suspend treatment was associated with significant psycho-
logical distress, and this was not associated with any particular patient
characteristics. Similarly, the psychological distress of patients whose
fertility treatment was delayed as a result of the COVID-19 pandemic
was investigated among 787 patients (response rate of 42.7%) in a sin-
gle-centre cross-sectional study from the USA (Lawson et al., 2021).
This survey, conducted in April/May 2020, used the Patient Health
Questionnaire-8 and the GAD-7 scale to estimate depressive symp-
toms and anxiety among participants and found that more than half of
the participants were experiencing moderate to severe anxiety (69–
74%) and symptoms of depression (77%). Age, duration of infertility,
social support and coping strategies were significantly associated with
depressive symptoms. Compared to these three studies investigating
psychological stress, (Boivin et al., 2020; Lawson et al., 2021; Marom
Haham et al., 2021), the anxiety levels that were observed in our
study were much lower (5.6%). This could be related to the differen-
ces in time periods of the COVID pandemic when the studies were
conducted. While the studies by Boivin et al. (2020), Marom Haham
et al. (2021) and Lawson et al. (2021) were all conducted in the initial
phase of the pandemic when fertility services were closed and no par-
ticular timeline for resumption of treatment was in place, our study co-
incided with the gradual resumption of fertility services. Another
reason for the contradictory findings could be differences in demo-
graphic, clinical and sociocultural factors between the study popula-
tions. The anxiety caused by uncertainty is likely to be lower when
assessed following a resumption of fertility services.
With regards to the issue of discontinuation of fertility treatments, a
cross-sectional online questionnaire study from the USA conducted in
April 2020 reported a small number of participants (6%) who were
willing to suspend fertility treatment, including IVF, during the COVID
pandemic (Vaughan et al., 2020). However, in our study, a compara-
tively higher number of participants (47.6%) were willing to suspend
fertility treatment during the COVID pandemic. The dissimilarities in
the study findings could possibly be attributed to differences in the
available information on the unfolding medical crisis. A sudden cancel-
lation of fertility services and limited information about the enormity of
the COVID pandemic crisis may have influenced the US participants’
attitudes towards suspending their fertility treatment: The current
study period coincided with the peak of the COVID pandemic and
probably the participants were more aware of the risks involved in
continuing the fertility treatment.
In the South Asian subcontinent, infertility is associated with social
stigma and infertile couples often face harassment and ostracism.
While the women are mostly blamed and bear the brunt of social iso-
lation and abuse, in some cases men also face ridicule and humiliation
(Mosalanejad et al., 2013). While the psychosocial ramifications of in-
fertility in the South Asian continent are significant, providing access to
fertility treatment is lower down the priority list for health policy mak-
ers owing to limited healthcare resources. There is very limited public
funding and insurance coverage for fertility treatment in India, there-
fore most of the treatments are self-funded. The COVID pandemic
and its negative impact on the economy have further complicated the
fertility treatment plans of many infertile couples. Treatment cancella-
tion and delays caused directly by the COVID pandemic, as well as
the indirect impact of financial constraints owing to salary cuts and job
losses, have increased the psychological stress. The country-specific

































































































guidelines issued by fertility societies suggested a gradual and judicious
resumption of fertility treatment depending upon the local prevalence
of COVID-19, government regulations and availability of resources
(Icmr.gov.in, 2021). Since most of the IVF clinics are located in larger
cities, for many infertile couples a resumption of their fertility treat-
ment entailed additional travel, staying in paid accommodations and an
increased duration of stay because of quarantine restrictions, further
increasing the indirect cost and risk of infection by SARS-CoV-2. A
cross-sectional study from a tertiary centre in North India evaluated
the apprehension and anxiety levels among infertile couples waiting for
the resumption of their fertility treatment during the COVID pandemic
(Gupta et al., 2021). They conducted an online questionnaire-based
survey and analysed responses from 170 participants between June
and August 2020. The authors reported that while 90% of the partici-
pants were worried about the delay in their fertility treatment, 64% of
them did not want to avoid pregnancy during the COVID pandemic,
which is in agreement with the current study finding. Among the sub-
set of women who were waiting for the resumption of IVF, a large ma-
jority (85%) expressed a desire to go ahead with embryo transfer
during the COVID pandemic. The authors suggested that the infertile
couples were more worried about the delay in fertility treatment and
its likely impact on their chances of success rather than the risk of
COVID-19 (Gupta et al., 2021).
The current study is one of the largest studies exploring the atti-
tudes of infertile couples towards the COVID pandemic and issues re-
lated to their fertility treatment in a resource-limited setting. Instead of
self-administered or postal questionnaires, the study involved inter-
viewer-administered questionnaires, which eliminated the missing or
invalid responses. The interviewers were not involved in the treatment
of the participating couples, thereby minimising bias. A validated anxi-
ety questionnaire suitable for the Indian setting (De Man et al., 2021)
was used in this study. Some limitations of the study need to be ac-
knowledged. A language barrier was encountered by some couples for
which assistance from a translator was sought. However, we had pro-
vided the information pamphlet and the questionnaire in four different
languages to mitigate this limitation and facilitate the survey.
Furthermore, questionnaire-based responses could have limited the
ability of the interviewer to capture the entire range of thoughts and
views of the participants on the COVID pandemic and their fertility
treatments.
The current survey was undertaken and completed during the peak
and post-peak phase of the first wave of the COVID pandemic in
India. During this period, there was some relaxation of the stringent
lockdown policies, which were originally introduced during the start of
the pandemic. In addition, regulatory policies on complete suspension
of elective treatments (such as fertility services) were changed gradu-
ally to facilitate the initiation of fertility treatments. It has to be noted
that the impact of the more recent, second wave of the COVID pan-
demic in India was more catastrophic than the first wave and the
healthcare system was stretched to the limits in many places. It is pos-
sible that if a similar survey was carried out during the second wave,
the results might have been different compared to the current study
findings. In spite of the uncertainties and changes over the past year,
the information gained from our survey helped to tailor the fertility
treatments according to the needs and concerns of the couples visiting
the clinic, as fertility services resumed gradually. In addition, while mak-
ing a conscious effort to reduce the number of hospital visits during
treatment, liberal use of tele-consultation, triaging of ART for certain
group of couples (e.g. diminished ovarian reserve, advancing age)
and encouragement for self-administration of hormone injections
during treatment were some of the interventions employed by
the unit to facilitate continuation of fertility treatment during the
COVID pandemic.
Overall, this study showed high levels of COVID-19 awareness
among infertile couples and low levels of anxiety related to COVID-19
in the context of fertility treatments. Adherence to COVID-19 preven-
tative norms helped in implementing secure measures in the fertility
clinic without much coercion. In spite of the pandemic and its associ-
ated risks, this study showed the willingness of infertile couples to initi-
ate/continue fertility treatment and lack of the need to delay or stop
the treatment. Given the psychosocial impact of infertility and the as-
sociated stigma, public health policy makers, regulatory authorities and
fertility societies should consider a way to sustain the treatment
options and develop appropriate guidelines to continue treatment,
particularly when much of the world is experiencing second and third
waves of the COVID pandemic.
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